Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Pillai

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Mutation Research|July 24, 1998
Effects of antimutagens on development of drug/antibiotic resistance in microorganismsS P Pillai, D M Shankel
Mutation Research|July 3, 1997
Polyamines and their potential to be antimutagensS P Pillai, D M Shankel
Medicinal Research Reviews|November 11, 1999
Multiple drug resistanceL A Mitscher, S P Pillai, E J Gentry, et al.
Mutation Research|September 12, 2001
The ability of certain antimutagenic agents to prevent development of antibiotic resistanceS P Pillai, C A Pillai, D M Shankel, et al.
Journal of Natural Products|November 2, 1999
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutationsS P Pillai, S R Menon, L A Mitscher, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|July 30, 2004
Antimutagenic/antioxidant activity of green tea components and related compoundsS P Pillai, L A Mitscher, S R Menon, et al.
Medicinal Research Reviews|July 1, 1997
Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituentsL A Mitscher, M Jung, D Shankel, et al.
Biofactors (Oxford, England)|February 24, 2001
Role of antimutagens/anticarcinogens in cancer preventionD M Shankel, S P Pillai, H Telikepalli, et al.
Journal of Natural Products|January 23, 1999
Structure-antimutagenic activity relationship study of plicatin BS R Menon, V K Patel, L A Mitscher, et al.
Veterinary and Comparative Oncology|May 9, 2013
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinomaC K Martin, W P Dirksen, M M Carlton, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Mutation Research|July 24, 1998
Effects of antimutagens on development of drug/antibiotic resistance in microorganismsS P Pillai, D M Shankel
Mutation Research|July 3, 1997
Polyamines and their potential to be antimutagensS P Pillai, D M Shankel
Medicinal Research Reviews|November 11, 1999
Multiple drug resistanceL A Mitscher, S P Pillai, E J Gentry, et al.
Mutation Research|September 12, 2001
The ability of certain antimutagenic agents to prevent development of antibiotic resistanceS P Pillai, C A Pillai, D M Shankel, et al.
Journal of Natural Products|November 2, 1999
Umbelliferone analogues and their potential to inhibit Benzo(a)pyrene- and hydrogen peroxide-induced mutationsS P Pillai, S R Menon, L A Mitscher, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|July 30, 2004
Antimutagenic/antioxidant activity of green tea components and related compoundsS P Pillai, L A Mitscher, S R Menon, et al.
Medicinal Research Reviews|July 1, 1997
Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituentsL A Mitscher, M Jung, D Shankel, et al.
Biofactors (Oxford, England)|February 24, 2001
Role of antimutagens/anticarcinogens in cancer preventionD M Shankel, S P Pillai, H Telikepalli, et al.
Journal of Natural Products|January 23, 1999
Structure-antimutagenic activity relationship study of plicatin BS R Menon, V K Patel, L A Mitscher, et al.
Veterinary and Comparative Oncology|May 9, 2013
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinomaC K Martin, W P Dirksen, M M Carlton, et al.
Pageof 1